#United States #Dallas #Vascular Health #Koya Medical #Dayspring

Koya Medical to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Koya Medical, a promising force in the healthcare technology sector, is gearing up to showcase its latest innovations at the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference, scheduled for March 16-19, 2026. The company’s CEO, Andy Doraiswamy, is set to take the stage on March 17 at 11:20 AM ET, highlighting Koya's trajectory, their commercial growth, and major developments in their product line.

Who is Koya Medical?

Founded in 2018 and based in Dallas, Koya Medical is carving a niche for itself in the healthcare landscape by focusing on patient-centered solutions that address peripheral vascular health. The company emerged from a desire to close treatment gaps and elevate the standards of care in vascular health—an area that significantly impacts millions of lives yet often goes unnoticed.

Why Vascular Health Matters

Vascular health issues, particularly venous and lymphatic diseases, affect over 35 million people in the United States alone. These conditions can lead to serious complications, affecting overall mobility, quality of life, and long-term health outcomes. Despite their prevalence, many patients struggle with a lack of effective treatments and resources aimed at improving their conditions.

Koya Medical aims to combat these challenges with innovative products such as the Dayspring® non-pneumatic compression treatment. This solution is designed to manage chronic edema and provides a new avenue of care for those living with chronic conditions associated with poor vascular health.

What to Expect at the Conference

During the presentation, Koya Medical’s CEO will delve into the company’s strategic growth and the clinical research supporting its product pipeline. Expect to hear detailed insights into how Koya is redefining the standards of care in vascular health and its plans for future innovations that could reshape the landscape of medical treatments for patients facing these challenging health issues.

The participation at the Oppenheimer conference marks a critical milestone for Koya Medical, as it seeks to attract potential investors and partners who share its vision for improving vascular health care solutions.

Those interested in learning about breakthroughs in medical technology and innovations in patient-centered care won't want to miss Koya Medical’s presentation. This is an opportunity not only to hear about advancements but also to understand how the industry is responding to the pressing need for more effective treatments.

Looking Ahead

As the conference approaches, Koya Medical continues to advocate for improved awareness and understanding of vascular health issues. By presenting at prominent events like this, the company is not just selling its products but also looking to change the conversation around care for peripheral vascular diseases.

Join the Conversation

For those looking to delve deeper into Koya Medical's efforts or to follow the journey of advancements in vascular health, more information can be found on their official website and their LinkedIn page. They invite patients, healthcare professionals, and stakeholders to engage with them in their mission to improve vascular health outcomes across the country.